Full Product Name
Bcr, phosphorylated (Tyr276) (Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, BCR1, D22S11)
Product Synonym Names
Anti -Bcr, phosphorylated (Tyr276) (Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, BCR1, D22S11)
Product Gene Name
anti-BCR antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 22; NC_000022.10 (23522402..23660224). Location: 22q11.23
3D Structure
ModBase 3D Structure for P11274
Specificity
Recognizes human Bcr, phosphorylated at Y276. Species Crossreactivity
Purity/Purification
Affinity Purified
Purified by immunoaffinity chromatography.
Form/Format
Supplied as a liquid in PBS, 0.05% BSA, 0.05% sodium azide.
Immunogen
Synthetic peptide corresponding to human Bcr/Abl protein containing a phosphorylated tyrosine residue at position 276.
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Other Notes
Small volumes of anti-BCR antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-BCR antibody
Bcr, receptor tyrosine kinase (also known as breakpoint cluster region or C-abl oncogene 1) is an intracellular protein belonging to the protein kinase superfamily and Tyr protein kinase family. It is a proto-oncogene with a SH2 domain, a SH3 domain and a protein kinase domain. Purified Bcr is known to contain autophosphorylation activity and transphosphorylation activity for several protein substrates. The function of this protein includes promoting the exchange of RAC or CDC42-bound GDP by GTP thereby activating them and hence acting as a GTPase activating protein. Moreover, PCAF and BCR signalling are essential for apoptotic cell death (PCAF and BCR signalling control cooperatively pre-mature B cell apoptosis via both depletions of DFFA and BIRC2). Ubiquitous expression of this protein is seen in most tissues. Bcr with Abl1, in reciprocal translocation between chromosomes 22 and 9, produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia.
Product Categories/Family for anti-BCR antibody
Antibodies; Abs to Protein Kinases
Applications Tested/Suitable for anti-BCR antibody
Western Blot (WB)
Application Notes for anti-BCR antibody
Suitable for use in Western Blot.
Dilution: Western Blot: 0.01-1ug/ml
NCBI/Uniprot data below describe general gene information for BCR. It may not necessarily be applicable to this product.
NCBI Accession #
CAA26441.1
[Other Products]
UniProt Primary Accession #
P11274
[Other Products]
UniProt Secondary Accession #
P78501; Q12842; Q4LE80; Q6NZI3[Other Products]
UniProt Related Accession #
P11274[Other Products]
Molecular Weight
142,819 Da[Similar Products]
NCBI Official Full Name
bcr
NCBI Official Synonym Full Names
breakpoint cluster region
NCBI Official Symbol
BCR [Similar Products]
NCBI Official Synonym Symbols
ALL; CML; PHL; BCR1; D22S11; D22S662
[Similar Products]
NCBI Protein Information
breakpoint cluster region protein; BCR/FGFR1 chimera protein; FGFR1/BCR chimera protein; renal carcinoma antigen NY-REN-26
UniProt Protein Name
Breakpoint cluster region protein
UniProt Synonym Protein Names
Renal carcinoma antigen NY-REN-26
Protein Family
Bicyclomycin resistance protein
UniProt Gene Name
BCR [Similar Products]
UniProt Synonym Gene Names
BCR1; D22S11 [Similar Products]
UniProt Entry Name
BCR_HUMAN
NCBI Summary for BCR
A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
UniProt Comments for BCR
Bcr: a protein with serine/threonine protein kinase activity and is a GTPase-activating protein (GAP) for RAC1 and CDC42. The amino-terminal region of Bcr contains an oligomerization domain, a serine/threonine kinase domain and a region that binds SH2 domains. The middle of the protein has a PH domain and a region of sequence similarity to the guanine nucleotide exchange factors for the Rho family of GTP binding proteins. The carboxy-terminal region promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. A breakpoint cluster region protein that participates in a t(9;22)(q34;q11) chromosomal translocation that produces a BCR-ABL oncogene responsible for chronic myeloid leukemia (CML), acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The function of wild type Bcr in cells remains unclear. PDGF receptor may use Bcr as a downstream signaling mediator. Tyr177 of human Bcr, phosphorylated in the Bcr-Abl fusion protein, provides a docking site for Gab2 and GRB2, and is important in the transforming activity of Bcr-Abl. Sequence variants of the Bcr protein may be associated with bipolar disorder. Two alternatively spliced isoforms of the human protein have been reported.
Protein type: Kinase, protein; EC 2.7.11.1; GEFs, Rac/Rho; Oncoprotein; GAPs, Rac/Rho; Protein kinase, atypical; Protein kinase, Ser/Thr (non-receptor); GAPs; ATYPICAL group; BCR family
Chromosomal Location of Human Ortholog: 22q11.23
Cellular Component: postsynaptic membrane; protein complex; membrane; postsynaptic density; cytosol; cell junction
Molecular Function: protein serine/threonine kinase activity; Rho guanyl-nucleotide exchange factor activity; protein binding; enzyme binding; protein-tyrosine kinase activity; kinase activity; ATP binding; GTPase activator activity
Biological Process: inner ear morphogenesis; peptidyl-tyrosine phosphorylation; regulation of cell cycle; protein amino acid autophosphorylation; response to lipopolysaccharide; platelet-derived growth factor receptor signaling pathway; signal transduction; protein amino acid phosphorylation; negative regulation of neutrophil degranulation; regulation of small GTPase mediated signal transduction; positive regulation of phagocytosis; small GTPase mediated signal transduction; negative regulation of inflammatory response; brain development; actin cytoskeleton organization and biogenesis; neuromuscular process controlling balance; negative regulation of cell migration
Disease: Leukemia, Acute Lymphoblastic; Leukemia, Chronic Myeloid
Research Articles on BCR
1. Suggest the existence of a feed-forward loop accelerating chronic myeloid leukemia progression, in which BCR-ABL1 enhances its own mutation rate in a STAT5-reactive oxygen species dependent manner.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.